| Literature DB >> 35983390 |
Aishwarya Singh1, Rohit Mishra1, Rajesh Ranjan2.
Abstract
Background Around 30% of the world's population suffers from iron deficiency anaemia (IDA). The standard evaluation for IDA involves upper and lower endoscopy, which allows for the confirmation of pathology of the gastrointestinal tract (GIT) induced due to IDA through iron malabsorption mechanism or loss of blood. Assessing the prevalence of lesions of GIT of significant nature among males having IDA, was the goal of our study. Methods Our cross-sectional study was conducted for two years and involved 152 males (adults) with confirmed cases of IDA from the Outpatient (OPD) and In-patient (IPD) in the present hospital. Following collecting consent (both informed and written in nature), patient-specific data was collected in a standardized form, and a blood sample was taken for laboratory testing. The analyses were done at a 5% level of significance; an association was considered significant if the p-value < 0.05. Results The average age of the study participants was 59.6 years. The commonest lesions reported were antral gastritis (9.9%) and H. pylori gastritis (7.2%) in upper GI; and haemorrhoid (9.2%) and anal fissure (3.9%) in lower GI. The overall prevalence of any GI lesions was 65.1%. The GI lesions were significantly associated higher among men with age > 50 years (73.7%). The presence of occult blood in stools (p < 0.0001) and parasites in stools (p=0.0001) were significantly related to the presence of GI lesions. Conclusion GI lesions are frequently detected in males with IDA. Whether it is symptomatic male or asymptomatic male with anaemia refractory to iron treatment, GIT should be evaluated in them.Entities:
Keywords: endoscopy; gastrointestinal tract lesions; inflammatory bowel diseases; iron deficiency anaemia; males
Year: 2022 PMID: 35983390 PMCID: PMC9376560 DOI: 10.7759/cureus.26905
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Baseline characteristics of the study subjects.
*Multiple responses
BMI: Body mass index, NSAID: Non-steroidal anti-inflammatory drugs, PPI: Proton pump inhibitor
| Variables | Number/Mean | %/SD |
| Age (in years) | 59.6 | 20.9 |
| Age group | ||
| <50 years | 55 | 36.1 |
| >50 years | 97 | 63.9 |
| Diet | ||
| Vegetarian | 98 | 64.5 |
| Mixed | 54 | 35.5 |
| BMI (kg/m2) | 21.9 | 3.8 |
| History of medication | ||
| No | 121 | 79.6 |
| NSAID | 9 | 5.9 |
| PPI | 22 | 14.5 |
| Comorbidities | ||
| No | 89 | 58.6 |
| Yes | 63 | 41.4 |
| If yes, comorbidity type* | ||
| Hypertension | 31 | 20.4 |
| Diabetes | 22 | 14.5 |
| Thyroid dysfunction | 6 | 3.9 |
| Others | 16 | 10.5 |
Signs and symptoms among study subjects.
*Includes GI symptoms, weight loss > 10 % in the previous year, abdominal pain, abdominal distention or bloating, weakness and easy fatigability
$ Multiple responses
GI: Gastrointestinal
| Variables | Number | % |
| Any symptoms* | ||
| Yes | 105 | 69.1 |
| No | 47 | 30.9 |
| GI Symptoms$ | ||
| No | 51 | 33.6 |
| Yes | 101 | 66.4 |
| If yes | ||
| Upper GI symptoms$ | 32 | 21.1 |
| Heart burn | 21 | 13.8 |
| Epigastric pain | 13 | 8.6 |
| Lower GI symptoms$ | 69 | 45.4 |
| Diarrhoea | 5 | 3.3 |
| Constipation | 31 | 20.4 |
| Change in bowel habits | 9 | 5.9 |
| Rectal bleeding | 32 | 21.1 |
| Physical examination findings | ||
| Hepatosplenomegaly | 7 | 4.6 |
| Epigastric sensitivity | 15 | 9.9 |
Laboratory findings of the study subjects.
MCV: Mean corpuscular volume
| Laboratory parameters | Number/Mean | %/SD |
| Haematological | ||
| Haemoglobin (g/dl) | 9.86 | 1.56 |
| MCV (fL) | 75.8 | 9.7 |
| Ferritin (ng/ ml) | 6.9 | 5.8 |
| Transferrin (g/L) | 7.2 | 3.1 |
| Faecal | ||
| Occult Blood | 56 | 36.8 |
| Parasites/Ova/Cysts | 21 | 13.8 |
Upper and lower GI lesions among the study subjects.
GI: Gastrointestinal
| Lesion | Number | % |
| Upper GI endoscopy | ||
| Not done | 68 | 44.7 |
| Done | 84 | 55.3 |
| If done, findings | ||
| Normal | 18 | 11.8 |
| Antral gastritis | 15 | 9.9 |
| H. pylori gastritis | 11 | 7.2 |
| Duodenitis | 8 | 5.3 |
| Pangastritis | 8 | 5.3 |
| Coeliac disease | 5 | 3.3 |
| Gastric ulcer | 4 | 2.6 |
| Duodenal ulcer | 3 | 2.0 |
| Atrophic gastritis | 3 | 2.0 |
| Interstitial colitis | 3 | 2.0 |
| Gastric polyp | 2 | 1.3 |
| Erosive gastritis | 2 | 1.3 |
| Gastric cancer | 1 | 0.7 |
| Lower GI endoscopy | ||
| Not done | 89 | 58.6 |
| Done | 63 | 41.4 |
| If done, findings | ||
| Normal | 30 | 19.7 |
| Haemorrhoid | 14 | 9.2 |
| Anal fissure | 6 | 3.9 |
| Colonic polyp | 5 | 3.3 |
| Diverticulitis | 4 | 2.6 |
| Chronic colitis | 2 | 1.3 |
| Inflammatory bowel disease | 1 | 0.7 |
| Colonic cancer | 1 | 0.7 |
| Any GI lesion | 99 | 65.1 |
Association of the clinical, laboratory and baseline characteristics with the GI lesions among the study subjects.
BMI: Body mass index, NSAID: Non-steroidal anti-inflammatory drugs, PPI: Proton pump inhibitor, GI: Gastrointestinal, MCV: Mean corpuscular volume
| Variables | GI lesion [Number (%)] | P value | |
| Yes (n=99) | No (n=53) | ||
| Age | |||
| <50 years | 26 (26.3) | 29 (54.7) | 0.0005 |
| >50 years | 73 (73.7) | 24 (45.3) | |
| BMI (kg/m2) | 23.1 ± 5.2 | 20.3 ± 4.1 | 0.0009 |
| Diet | |||
| Vegetarian | 58 (58.6) | 40 (75.5) | 0.038 |
| Mixed | 41 (41.4) | 13 (24.5) | |
| History of medication | |||
| NSAID | 6 (6.1) | 3 (5.7) | 0.920 |
| PPI | 19 (19.2) | 3 (5.7) | 0.028 |
| Comorbidities | |||
| No | 57 (57.6) | 32 (60.4) | 0.738 |
| Yes | 42 (42.4) | 21 (39.6) | |
| Any GI symptoms | |||
| Yes | 75 (75.8) | 26 (49.1) | 0.008 |
| No | 24 (24.2) | 27 (50.9) | |
| Haematological | |||
| Haemoglobin (g/dL) | 8.6 ± 1.7 | 10.2 ± 1.4 | <0.0001 |
| MCV (fL) | 74.9 ± 8.2 | 75.6 ± 7.8 | 0.610 |
| Ferritin (ng/ml) | 6.3 ± 5.7 | 5.9 ± 4.3 | 0.655 |
| Transferrin (g/L) | 8.3 ± 2.9 | 7.7 ± 3.5 | 0.260 |
| Faecal | |||
| Occult Blood | 25 (25.3) | 31 (58.5) | <0.0001 |
| Parasites/Ova/Cysts | 6 (6.1) | 15 (28.3) | 0.0001 |